Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse

Diabetes

Volumn 46, Issue 5, 1997, Pages 750-757

  O'Brien, Bronwyn A ^a   Harmon, Brian V ^a   Cameron, Donald P ^b   Allan, David J ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL DEATH; FEMALE; HORMONE DETERMINATION; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0030937468     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.5.750     Document Type: Article

References (60)

1. Gepts W, Lecompte PM: The pancreatic islets in diabetes. Am J Med 70:105-115, 1980
2. Eisenbarth GS: Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 21:1360-1368, 1986
3. Nerup J, Mandrup-Paulsen T, Mølvig J: The HLA-IDDM association: implications for aetiology and pathogenesis of IDDM. Diabetes Metab Rev 3:779-802, 1987
4. Nerup J, Mandrup-Paulsen T, Mølvig J, Helqvist J, Wogensen LD: On the pathogenesis of insulin-dependent diabetes mellitus - a discussion of three recently proposed models. In Diabetes Mellitus: Pathophysiology and Therapy. Creutzfeldt W, Lefèbvre P, Eds. Berlin, Springer-Verlag, 1984, p. 39-50
5. Mandrup-Paulsen T: On the pathogenesis of insulin-dependent diabetes mellitus. Dan Med Bull 35:438-460, 1988
6. Logothetopoulos J, Valiquette N, Cvet D: Glucose stimulation of β-cell DNA replication in the intact rat and in pancreatic islets in suspension culture: effects of alpha-ketoisocaproic acid, dibutyryl cyclic AMP and 3-isobutyl-1-methylxanthine in the in vitro system. Diabetes 32:1172-1177, 1983
7. De Vroede MA, In't Veld PA, Pipeleers DG: Deoxyribonucleic acid synthesis in cultured rat pancreatic B cells. Endocrinology 127:1510-1516, 1990
8. Swenne I: Pancreatic β-cell growth and diabetes mellitus. Diabetologia 35:193-201, 1992
9. Rabinovitch A, Blondel B, Murray T, Mintz DH: Cyclic adenosine-3′,5′-monophosphate stimulates islet β-cell replication in neonatal rat pancreatic monolayer cultures. J Clin Invest 66:1065-1072, 1980
10. Eizirik DL, Sandler S, Palmer JP: Repair of pancreatic β-cells: a relevant phenomenon in early IDDM? Diabetes 42:1383-1391, 1993
11. Kerr JFR, Winterford CM, Harmon BV: Apoptosis: its significance in cancer and cancer therapy. Cancer 73:2013-2026, 1994
12. Allan DJ: Radiation-induced apoptosis: its role in a MADCaT (mitosis-apoptosis-differentiation-calcium toxicity) scheme of cytotoxicity mechanisms. Int J Radiat Biol 62:145-152, 1992
13. O'Brien BA, Harmon BV, Cameron DP, Allan DJ: Beta cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J Pathol 178:176-181, 1996
14. Makino S, Tochino Y: The spontaneously non-obese-diabetic mouse. Exp Anim 27:27-29, 1978
15. Tochino YA: New type of nonobese diabetic mouse accompanied with sudden onset and insulitis. Saishin Igaku 34:1183-1188, 1979
16. Makino S, Kunimoto D, Muraoka D, Mizuchima Y, Katagiri K, Tochino Y: Breeding of non obese, diabetic strain of mice. Exp Anim 29:1-30, 1980
17. Makino S, Hayashi Y, Muraoka Y, Tochino Y: Establishment of the nonobese diabetic (NOD) mouse. In Current Topics in Clinical and Experimental Aspects of Diabetes Mellitus. Sakamoto N, Ed. Amsterdam, Elsevier, 1985, p. 25-32
18. Makino S, Hayashi Y: Genetic analysis for insulitis in the mouse. In Insulitis and Type I Diabetes - Lessons From the NOD Mouse. Tarui S, Tochino Y, Nonaka K, Eds. New York, Academic, 1986, p. 23-31
19. Prochazka M, Gaskins HR, Shultz LD, Leiter EH: The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 89:3290-3294, 1992
20. Kerr JFR, Winterford CM, Harmon BV: Morphological criteria for identifying apoptosis. In Cell Biology: A Laboratory Handbook. Celis JE, Ed. San Diego, Academic, 1994, p. 319-329
21. Lorenzo A, Razzabon B, Weir GC, Yankner BA: Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368:756-760, 1994
22. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T, Taniguchi N: Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44:733-738, 1995
23. Rabinovitch A, Suarez-Pinzon WL, Shi Y, Morgan AR, Bleackley RC: DNA fragmentation is an early event in cytokine-induced islet β-cell destruction. Diabetologia 37:733-738, 1994
24. Ankarcrona M, Dypbukt JM, Brune B, Nicotera P: Interleukin-1-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 213:172-177, 1994
25. Bursch W, Paffe S, Putz B, Barthel G, Schulterhermann R: Determination of the length of the histological stages of apoptosis in normal liver and altered hepatic foci of rats. Carcinogenesis 11:847-853, 1990
26. Wyllie AH, Kerr JFR, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 68:251-306, 1980
27. Kanazawa Y, Komeda K, Sato S, Mori S, Akanuma K, Takaku F: Non-obese-diabetic mice: immune mechanisms of pancreatic β-cell destruction. Diabetologia 27:113-115, 1984
28. Wicker LS, Miller BJ, Mullen, Y: Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35:855-860, 1987
29. Maruyama T, Takai I, Taniyama M, Kataoka K, Matsuki S: Immunological aspect of non-obese diabetic mice: murine islet cell-killing mechanism and cell-mediated immunity. Diabetologia 27:121-123, 1984
30. Wang Y, Hao L, Gill RG, Lafferty KJ: Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes 36:535-538, 1987
31. Dardenne M, Lepault F, Bendelac A, Bach JF: Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur J Immunol 19:889-895, 1989
32. + T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc Natl Acad Sci USA 88:527-531, 1991
33. Sanderson CJ, Thomas JA: The mechanism of K cell (antibody-dependent) cell mediated cytotoxicity: characteristics of the effector cell and morphological changes in the target cell. Proc R Soc Lond (Biol) 197:417-424, 1977
34. Bishop CJ, Whiting VA: The role of natural killer cells in the intravascular death of intravenously injected murine tumour cells. Br J Cancer 48:441-444, 1983
35. Stacey NH, Bishop CJ, Halliday JW, Halliday WJ, Cooksley WGE, Powell LW, Kerr JFR: Apoptosis as the mode of cell death in antibody-dependent lymphocytotoxicity. J Cell Sci 74:169-179, 1985
36. Golstein P, Ojcius DM, Young DE: Cell death mechanisms and the immune system. Immunol Rev 121:29-64, 1991
37. Ju S-T: Distinct pathways of CD4 and CD8 cells induce rapid target DNA fragmentation. J Immunol 146:812-818, 1991
38. Russell SW, Masakowski V, Rucinsky T, Phillips G: Mechanisms of immune lysis III: characterization of the nature and kinetics of the cytotoxic T lymphocyte-induced nuclear lesion in the target. J Immunol 128:2087-2094, 1982
39. Monti D, Cossarizza A, Salvioli S, Franceschi C, Rainaldi G, Straface E, Rivabene R, Malorni W: Cell death protection by 3-aminobenzamide and other poly(ADP-ribose) polymerase inhibitors: different effects on human natural killer and lymphokine activated killer cell activities. Biochem Biophys Res Commun 199:525-530, 1994
40. Pender MP, Nguyen KB, McCombe PA, Kerr JFR: Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 104:81-87, 1991
41. Darmon AJ, Nicholson DW, Bleackley RC: Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377:446-448, 1995
42. Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317-1330, 1994
43. Morris RG, Hargreaves AD, Duvall E, Wyllie AH: Hormone induced cell death 2. Surface changes in thymocytes undergoing apoptosis. Am J Pathol 115:426-436, 1984
44. Wyllie AH: The biology of cell death in tumours. Anticancer Res 5:131-136, 1985
45. Suenaga K, Yoon JW: Association of β-cell-speciflc expression of endogenous retrovirus with development of insulitis and diabetes in NOD mouse. Diabetes 37:1722-1726, 1988
46. Nakagawa C, Hanafusa T, Miyagawa J, Yutsudo M, Nakajima H, Yamamoto K, Tomita K, Kono N, Hakura A, Tarui S: Retrovirus gag protein p30 in the islets of non-obese diabetic mice: relevance for pathogenesis of diabetes mellitus. Diabetologia 35:614-661, 1992
47. Hao W, Serreze DV, McCulloch DK, Neifing JL, Palmer JP: Insulin (auto)antibodies from human IDDM cross-react with retroviral antigen p73. J Autoimmun 6:787-798, 1993
48. Gaskins HR, Prochazka M, Hamaguchi K, Serreze DV, Leiter EH: Beta cell expression of endogenous xenotropic retrovirus distinguishes diabetes-susceptible NOD/Lt from resistant NON/Lt mice. J Clin Invest 90:2220-2227, 1992
49. Haywood AM: Patterns of persistent viral infections. N Engl J Med 315:939-948, 1986
50. Notkins AL, Onodera T, Prabhakar B: Virus-induced autoimmunity. In Concepts in Viral Pathogenesis. Notkins AL, Oldstone MBS, Eds. New York, Springer-Verlag, 1984, p. 210-215
51. Pak CY, Eun HM, McArthur RG, Yoon J-W: Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 2:1-4, 1988
52. Hess EV, Farhey Y: Etiology, environmental relationships, epidemiology, and genetics of systemic lupus erythematosus. Curr Opin Rheumatol 7:371-375, 1995
53. Kalden JR, Gay S: Retroviruses and autoimmune rheumatic diseases. Clin Exp Immunol 98:1-5, 1994
54. Abraham GN, Khan AS: Human endogenous retroviruses and immune disease. Clin Immunol Immunapathol 56:1-8, 1990
55. Mountz JD, Talal N: Retroviruses, apoptosis and autogenes. Immunol Today 14:532-536, 1993
56. Wu J, Zhou T, He J, Mountz JD: Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 178:461-168, 1993
57. Bonnevie-Nielson V, Steffes MW, Lernmark A: A major loss in islet mass and β-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Diabetes 30:424-429, 1981
58. Lee KU, Amano K, Yoon JW: Evidence for initial involvement of macrophage in development of insulitus in NOD mice. Diabetes 37:989-991, 1988
59. Horio F, Fukuda M, Katoh H, Petruzzelli M, Yano N, Rittershaus C, Bonner-Weir S, Hattori M: Reactive oxygen intermediates in autoimmune islet cell destruction of the NOD mouse induced by peritoneal exudate cells (rich in macrophages) but not T cells. Diabetologia 37:22-31, 1994
60. Yahya MD, Pinnas JL, Meinke GC, Lung CC: Antibodies against malondaldehyde (MDA) in mrl/lpr/pr mice: evidence for an autoimmune mechanism involving lipid peroxidation. J Autoimmun 9:3-9, 1996